Forex Word PressIntegrated Forex Experiences And Forex Information That Useful In Trading

Investors' Insatiable Appetite for Chinese IPO's and Public Companies Doing Business in China China-AsiaStocks.com Reports on Listings from Shanghai to Hong Kong to U.S. Markets, Updating Growing Stock Directory for Investors Following Sector. PR9.NET November 13, 2007 - POINT ROBERTS, Wash., Delta B.C., - InvestorIdeas.com and China-AsiaStocks.com, its investor and industry portal focused on the China-Asia sector, updates its growing stock directory with new public company listings as investors witness the China IPO frenzy and seek investment opportunities in the sector. From Shanghai's listing of oil and gas conglomerate, PetroChina- China's largest domestic IPO, to the recent Alibaba.com IPO on the Hong Kong stock exchange, the market can't fill the growing appetite for China related listings. According to a recent report by Ernst & Young, companies in mainland China and Hong Kong raised $14.3 billion in the third quarter and the number of company listings in Hong Kong and mainland China hit new records. Philip Leung commented in their release "The record number of IPO's shows that companies were quick to react to keen investor interest in equities ". Outside of American Depositary Shares (ADS), investors can also invest in the China play in the micro cap markets. After Market Support, LLC, a wholly owned subsidiary of Keating Investments, is a financial marketing firm specializing in creating liquidity for publicly traded stocks and has worked with multiple clients that have gone public through reverse mergers (a method of going public increasingly replacing IPOs for micro cap issuers). Keating has an office and division in Shanghai (www.keatingasia.com) According to Justin Davis of After Market Support, LLC., currently working with Benda Pharmaceutical, Inc., (OTCBB: BPMA), smaller listed companies can provide investors the opportunity to get in on the ground floor of China's dramatic growth story. Justin does advise investors to complete their own due diligence and review SEC filings prior to investing. Benda Pharmaceutical (OTCBB: BPMA) is building its presence within the fast growing Chinese market and beyond, forecasting that Gendicine® will generate $16 million in revenue in 2008, up from estimates of $6.2 million for 2007. In total, the Company anticipates revenues to reach $25.1 million in 2007 and progressing upwards to $56.7 million in 2008. Yahoo!s (NASDAQ: YHOO) US$1 billion investment (40% interest) in Alibaba's business-to-business trading portal, represents another alternative for U.S. investors looking to participate in and own shares in companies doing business in China . Some notable recent and pending China listing market debuts include- Longtop's (NYSE:LFT) American Depositary Shares, posting significant gains its first day of trading Longtop, provides information technologies services to China's financial services sector. Also making headlines- China National Heavy Duty Truck Co, a heavy truck maker, in a Hong Kong IPO and Giant Interactive Group Inc ADSs (NYSE: GA), an online game developer . In the pipeline is AirMedia, planning to list its ADSs on NASDAQ, trading symbol AMCN. FUQI International, Inc. (NASDAQ: FUQI) recent IPO at $9.00 has already had a range of $6.50 - $11.75 and is currently down from its IPO debut. FUQI International, Inc. designs high quality precious metal jewelry in China.

Investorideas.com Reports on Resource Based Public Companies Strategies and Relationships with First Nations; Featuring Exclusive Audio Interviews with Industry and First Nation Leaders Curtis Rattray, Chairman of the Central Council Tahltan Nation and Rick Van Nieuwenhuyse, President and CEO of NovaGold Resources Inc. (TSX: NG)(AMEX:NG) Provide Insight into Blending First Nations Culture and Corporate Culture to Create a Winning Formula a leading global investor and industry research resource portal specialized in sector investing reports on resource based public companies in Canada and relationships and strategies regarding First Nations. As investors read headlines of blockades and litigation, it is fast becoming a necessary part of investor due diligence to review and consider each public company policy and strategy regarding First Nations and the underlying natural resources. In the first of a new series, Investorideas.com discusses this highly volatile issue with representatives of public companies, industry members and the First Nations community including Chief Paul Eshkakogan, Curtis Rattray, Chairman of the Central Council Tahltan Nation, Rick Van Nieuwenhuyse, President and CEO of NovaGold Resources Inc.(TSX:NG)(AMEX:NG), Donald A. McInnes, Vice-Chairman and CEO of Plutonic Power Corp (TSX:PCC), industry consultants Brian Davey, First Nations Equity Inc and Jessica Delaney, VP of PR Associates. At the recently held Canadian Aboriginal Mining Association Conference (CAMA) in Vancouver one of the panelists, Chief Paul Eshkakogan, Sagamok Anishnawawbek, commented when asked by an audience member what companies have done it right "Nobody has got it right yet, there is a lot more room for improvement." In an interview with Investorideas.com Chief Paul Eshkakogan went on to discuss two mining deals they have entered into in Northern Ontario and how the resulting deals have improved working opportunities for his people but have yet to include royalty deals. They have currently signed an interim measures agreement with URSA Major Minerals Incorporated (TSX: UMJ) http://www.ursamajorminerals.com/ and an MOU with CVRD Inco. http://www.inco.com/

NYC Symposium to Explore The Economic State of Green Building The Green Building Industry's Top Analyst and New York's Green Financial Advisor aim to educate Eco Investors and take Green Building to new heights San Diego, CA. Nov 7, 2007 - Harvey Bernstein of McGraw-Hill Construction and Bruce Kahn, Citi Smith Barney's Green Financial Advisor, will come together to explore the riveting topic of "The Economic State of Green Building" at the Eco Investment Club's Symposium on November 19th, 6-8PM. These industry leaders will discuss Economic Forecasts, the current state of Green Building, the principles of Investing in "Green" and current Industry Trends, all of which will be held above the Manhattan skyline at Citi Smith Barney's Park Avenue offices. "Those that invest (in Green Buildings) understand the advantages of green design-from the health benefits and the resource (energy, water, etc.) conservation. Both of those save $$ for owners, and those concepts have traction now in the marketplace," said Harvey Bernstein, Vice President of Industry Analytics, Alliances and Strategic Initiatives for McGraw-Hill Construction in a recent interview with Yeves Perez, Founder of the Eco Investment Club. Bernstein then added, "However, that is the part of the population that has been exposed to that level of education, and the reality is that we as "information providers" still have our work cut out for us in reaching those investors who aren't as aware of how the market is shifting. It's an exciting opportunity, though, to be helping to push what is now a fully emerging trend to one that becomes standard". The complete interview with Mr. Bernstein will be featured in the up coming article, "What Green Invest ors Should Know About Investing in Green Buildings," released this Friday, November 16th. Mr. Bernstein had also commented on the touchy "ROI" questions saying, "Our Commercial Green Building SmartMarket Report has shown that (Green) building owners expect decreases of operating costs between 8% and 9%, average increases expected of around 7.5% in building values, an ROI improvement of 6.6%, occupancy ratio expected to increase by 3.5% on average and rent increasing by three percent on average". Admission to this insightful event is Free, yet pre-registration is required due to building security. For more information, visit the Eco Investment Club's website at www.EcoInvestmentClub.com . About Eco Investment Club The Eco Investment Club was designed to facilitate a positive atmosphere where Eco-Investors, Green Entrepreneurs, and like-minded individuals can become a part of a group that: provides exceptional educational opportunities; shares eco-investment opportunities; encourages the forming of new partnerships; provides in-depth news and pertinent information about the Green Industry and Eco Investing; supports the progression of The Green Movement.

Ardour Global Index , A Global Alternative Energy Index, Up 59.38 Percent Through October Constituents Derive at Least 50% of Revenues from Alternative Energy. Approximately 69 Percent of Index is International and 81 Percent is in Renewable Energy Companies NEW YORK -- The Ardour Global Index(SM) (Extra Liquid) (AGIXLT) rose 13.77 percent in October and gained 59.38 percent in the ten months ending October 31, 2007.*(+) AGIXLT is a rules based index intended to give investors a means of tracking the overall performance of a global universe of listed companies engaged in the alternative energy industry. These companies derive at least 50% of their revenues from the industry. Together, companies in the Index participate in a broad range of alternative energy activities; however, approximately 81% of the Index's components are classified as being in renewable energy (solar, wind, ethanol, bio-fuels, water and geothermal). AGIXLT is calculated using a modified capitalization weighted methodology, adjusted for float. It includes 30 securities and is rebalanced quarterly. The next rebalancing will occur on December 21, 2007. The Market Vectors - Global Alternative Energy ETF (NYSE: GEX) is an exchange-traded fund that seeks to replicate, as closely as possible before fees and expenses, the price and yield performance of AGIXLT. The Fund generally holds all securities that comprise AGIXLT in proportion to their weighting in AGIXLT. *Past performance does not guarantee future results. AGIXLT's return does not represent the performance of any fund. AGIXLT charges no fees, including management fees or brokerage expenses, and no such fees or expenses were deducted from the performance shown. Investors cannot invest directly in AGIXLT. Please call 1.888.MKT.VCTR or visit www.vaneck.com/gex for the most recent month-end performance of Market Vectors-Global Alternative Energy ETF. This information will be available no later than seven business days after the most recent month end. (+)About the Ardour Global Index (Extra Liquid) (AGIXLT) AGIXLT, a trademark of Ardour Global Indexes(SM), LLC, is licensed for use by Van Eck Associates Corporation in connection with the Fund. Ardour Global Indexes(SM), LLC does not sponsor or endorse the Fund and it makes no warranty or representation as to its accuracy and/or completeness or results to be obtained by any person from use of AGIXLT in connection with trading of the Fund. The value of AGIXLT is disseminated every 15 seconds between the hours of approximately 9:30 a.m. and 4:15 p.m. Eastern Time. The Index is a total return index. Although Fund shares may be bought and sold in the secondary market through any brokerage account, Fund shares are not individually redeemable from the Fund. Investors may acquire Fund shares and tender them for redemption through the Fund only in large, specified blocks of shares. The Fund is subject to risks associated with the stock market, index tracking, sector investing, investing in small- or mid-cap companies, replication management, non-diversified investments, absence of prior active market, trading issues, fluctuation of net asset value and risks of investing in alternative energy investments. Because of their narrow focus, sector investments tend to be more volatile than investments that diversify across many sectors and companies. Investors may call 1.888.MKT.VCTR or visit www.vaneck.com/gex for a free prospectus. Investors should consider the investment objective, risks, and charges and expenses of Market Vectors-Global Alternative Energy ETF carefully before investing. The prospectus contains this and other information about the Fund. Please read the prospectus carefully before investing. About Exchange-Traded Funds ETFs are passively managed baskets of securities that trade in a manner similar to stocks. They have grown in popularity as investment tools because of their relatively low expense ratios and the tax efficiency they offer compared to most mutual funds. Investors can buy and sell ETFs intra-day and they can hold them both long and short, offering the opportunity to prosper from both bear and bull markets. About Ardour Global Indexes(SM), LLC Ardour Global Indexes(SM), LLC was founded in 2005 for the express purpose of developing benchmarking tools for the global alternative energy industry. It is a partnership between Ardour Capital Investments(SM), a premier investment bank specializing in alternative energy finance, and S-Network Energy Technologies(SM), LLC, a developer of indexes and investment products focused on both traditional and alternative energy.

Trouble Is Brewing In the New Year - Brief Article While the economic environment in 2000 remains very strong, competition is heading up. Costs won't be an easy to control as they were in the last six years. Globalization, platform rationalization, consolidation, acquisitions, brand management, divestitures and reorganizations ... the 1990s was the decade of grand strategic moves by auto companies as they maneuvered to gain a structural advantage over the competition. The largest automakers are very different businesses today than they were at the start of the decade. But are they ready for the changes that will be thrown at them in the next decade, especially if the strong U.S. market erodes? Getting rid of non-core and low-profit operations improved the financial performance of Ford, General Motors and others in the last decade. And it sure didn't hurt that the American marketplace was incredibly favorable for U.S. auto companies. Stable demand, record light-truck sales, low inflation and successful programs to cut production costs contributed more to the record cash balances of these companies than all of the other initiatives. What is disturbing, however, is the loss of market share during the decade, especially at GM. This raises obvious questions about how American auto companies will fare when the business shifts. The underpinnings of the U.S. vehicle market were less favorable in 1999, despite record sales. Incentives are rising, light-truck supply now exceeds demand, higher gasoline prices will cause shoppers to wonder if they should really purchase a gas-guzzler and domestic brands have made no headway in the growing and profitable luxury-car segment. Over the past few years, sales of foreign brand vehicles have grown faster than domestic-brands car and light trucks, despite many billions of dollars invested by the domestic automakers in new models and the factories that build them. With no fanfare, Toyota emerged more dominant than it was at the start of the 1990s. Although a recession at home and the strong yen battered its profits, the company continued to expand by taking advantage of opportunities and solving product problems. Toyota admitted that young buyers in Japan find some of its cars stale because they are aimed at older consumers. Toyota responded quickly with new models and Gazu, its Internet service that is aimed directly at that audience. Toyota is poised to re-establish itself with this group. By contrast, American auto companies have been losing share to European luxury makes for 30 years and 1999 saw the erosion rate get worse. In the United States, Toyota expanded its upscale Lexus lineup to include less expensive cars and light trucks. Initial forays into large pickup trucks and minivans were not that successful. But Toyota learned from its experience. When the Sienna minivan and Tundra full-size pickup were launched last year, they quickly captured share in these segments. Changes have taken place in Toyota management, in the structure of the company and, recently, in the listing on the London and New York stock exchanges. It absorbed Daihatsu and Hino and is now building an assembly plant in France, after establishing a manufacturing presence in Latin America. Toyota cars are often discounted today rather than selling at list price, but the company has still been able to grow where others have not. The message here is very simple. Car buyers don't care how auto companies are organized. They don't care what they call their product development and marketing systems or whether they are vertically integrated or completely dependent on outside suppliers. Consumers only care that the vehicle they buy meets or exceeds their expectations and retains its value. Companies that deliver that gain share and those that don't give up share.

Rotoblock Corporation , developer of an advanced Oscillating Piston Engine (OPE) technology, announced today that Chinese-American entrepreneur Mr. Liu Chien-Chih has agreed to join as Chief Executive Officer. Mr. Liu has over 15 years' experience in international trade, marketing and manufacturing. Born in Taiwan, Mr. Liu immigrated with his family to the USA at the age of 10. Fluent in English and several Chinese dialects, Mr. Liu earned a Bachelor of Science Degree in Chemical Engineering from the University of California at Berkeley. Since that time he has spent much of his career capitalizing on new ideas and technologies and sees an opportunity with Rotoblock. "China is going through an industrial revolution and I see the market for small engines and advanced drive train development exploding with new technologies and economic growth," said Mr. Liu. "Rotoblock will explore the commercialization of the oscillating piston engine in China as well as pursue new opportunities for developing new products, commercializing the brand and distributing it worldwide." Prior to joining Rotoblock, Mr. Liu served for more than five years as a Vice President for Tianyi Group of Nanjing, China, a multi-billion dollar conglomerate involved in the manufacturing of automotive components and commercial equipment with over 10 subsidiaries. Mr. Liu served a variety of roles with Tianyi Group, which operates several factories in China. He managed Tianyi's extensive portfolio of real estate developments and other investments. He also managed the subsidiary Hikom/Goettel, one of the largest manufacturers of air conditioning in China. Hikom is the sole sponsor of the Shanghai Sharks Professional Basketball team, for which Yao Ming played before being recruited to the NBA. "I am committed to devoting 100 percent of my time to growing Rotoblock," said Mr. Liu. "With the experience and relationships developed with Tianyi Group, I believe I can take Rotoblock to new levels." "I congratulate Mr. Liu on his new venture and wish him nothing but success," said Tianyi Group Chairman and CEO Mr. Jiang Guobei. "I have every confidence in his ability to grow this company. Mr. Liu has a keen eye for new opportunities and taking them to completion and he will be missed here at Tianyi Group." Rotoblock About Rotoblock Corporation -- Rotoblock is focused on the development of leading-edge power train technologies including the development of its patented Oscillating Piston Engine technology. Rotoblock has signed a licensing agreement with OBVIO! Automotoveiculos S.A. of Brazil. The company was incorporated in Nevada and is headquartered in Santa Rosa, California. The Company has full rights to the patents of the Oscillating Piston Engine and believes the OPE technology has useful applications in an endless number of areas where its powerful, lightweight, efficient design are in ever-increasing demand. Visit Rotoblock's corporate website for details about the company, technology, and regulatory filings. The address is: http://www.rotoblock.com.

Benda Pharmaceutical, Inc. ("Benda" or the "Company") (OTCBB: BPMA), a China-based pharmaceutical company producing traditional Chinese and conventional medicines, as well as Gendicine®, the world's first commercialized gene therapy medicine for the treatment of cancer, announced today that its subsidiary SiBiono has made major strides in developing an anti-AIDS gene therapy. This marks SiBiono's and Benda's anticipated entry into the $14 billion Chinese anti-AIDS drug market. SiBiono Partners with DNAVEC to Develop Anti-AIDS Gene Therapy As the producer of the world's first commercialized gene therapy drug, SiBiono is acknowledged as a biopharmaceutical pioneer. In May 2007, leading Japanese gene therapy research institute DNAVEC sought out and formed a joint venture with SiBiono to develop the SeV-Gag vaccine, an anti-AIDS gene therapy treatment. DNAVEC designed and constructed the SeV-Gag vaccine several years ago and has patented it in both the United States and China. However, DNAVEC lacks the resources and experience to complete clinical trials and produce the drug on a commercial scale. Under the terms of the joint venture agreement, DNAVEC will leverage SiBiono's proven gene therapy manufacturing platform and will transfer the exclusive development and distribution rights of SeV-Gag in China to SiBiono. SiBiono will be responsible for completing the preclinical tests, clinical trials and manufacturing tests of the SeV-Gag vaccine in China. SiBiono will also seek all related Chinese State Food and Drug Administration (SFDA) approval. All scientific findings resulting from the development processes will be co-patented by both SiBiono and DNAVEC. SiBiono expects to obtain the required "New Drug Certificate" from the SFDA between 2012 and 2018. "We deliberately selected SiBiono as our partner from hundreds of other leading biopharmaceutical firms because of its unparalleled expertise and technological superiority in developing, manufacturing and commercializing gene therapy treatments," stated DNAVEC CEO Dr. Mamoru Hasegawa. "SiBiono's demonstrated clinical success with Gendicine® is a feat no one else in the world has yet matched, and we firmly believe that the joint venture with SiBiono provides us the best opportunity to realize our dream and bring the SeV-Gag vaccine to market." China's $14 Billion Anti-AIDS Drug Market A 2006 study conducted by the AIDS research center in Tsinghua University, China's leading scientific research institute, revealed that more than one million Chinese patients were infected with human immunodeficiency virus (HIV). Other studies predicted that this number could grow exponentially in the next 10 years and that China, even with increased prevention education, will likely see 10 million HIV-infected patients by the end of 2010. The average annual treatment cost for American HIV patients is $20,000, while the cost for Chinese patients is only approximately $1,400. However, with more government funding allocated to the cause and the increasing wealth of the population, Chinese AIDS treatment costs are expected to rise in the coming years. But even at the current average annual cost of $1,400, the likely 10 million HIV infected patients by 2010 could create a $14 billion anti-AIDS drug market in China. Imported anti-AIDS drugs are often too expensive for typical Chinese patients, driving a need for innovative, affordable domestic drugs. SeV-Gag Development The development of SeV-Gag is led by Mr. Yi Zeng, who has been enlisted as the Chief Scientist for the project. Mr. Zeng is the only Chinese member of the UNAIDS Asia Pacific Leadership Forum on HIV/AIDS and Development. He is also the Chief Scientist of the Institute of Viral Disease Control and Prevention at the Chinese Center of Disease Control.